Fangfang Zhong

881 total citations
55 papers, 680 citations indexed

About

Fangfang Zhong is a scholar working on Molecular Biology, Plant Science and Physiology. According to data from OpenAlex, Fangfang Zhong has authored 55 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 11 papers in Plant Science and 7 papers in Physiology. Recurrent topics in Fangfang Zhong's work include Photosynthetic Processes and Mechanisms (11 papers), Natural Compound Pharmacology Studies (8 papers) and Phytochemistry and Biological Activities (7 papers). Fangfang Zhong is often cited by papers focused on Photosynthetic Processes and Mechanisms (11 papers), Natural Compound Pharmacology Studies (8 papers) and Phytochemistry and Biological Activities (7 papers). Fangfang Zhong collaborates with scholars based in China, United States and Macao. Fangfang Zhong's co-authors include Ekaterina V. Pletneva, Guangzhong Yang, Yu Chen, George P. Lisi, Xiangshi Tan, Jifu Li, Zhong‐Xian Huang, Stephanie Alden, Tianlei Ying and Jingjing Du and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Fangfang Zhong

50 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangfang Zhong China 17 386 136 94 56 55 55 680
Joan Villena Chile 16 384 1.0× 180 1.3× 94 1.0× 74 1.3× 49 0.9× 64 805
Nuno Saraiva Portugal 18 391 1.0× 122 0.9× 92 1.0× 81 1.4× 91 1.7× 47 847
Jayant Dewangan India 14 380 1.0× 170 1.3× 47 0.5× 122 2.2× 110 2.0× 20 768
Bartolo Favaloro Italy 12 595 1.5× 58 0.4× 56 0.6× 72 1.3× 55 1.0× 21 906
Chi‐Ching Hwang Taiwan 19 501 1.3× 53 0.4× 95 1.0× 39 0.7× 77 1.4× 47 883
Takashi Tsujimoto Japan 15 314 0.8× 134 1.0× 107 1.1× 19 0.3× 60 1.1× 36 787
Xiaoning Li China 17 497 1.3× 72 0.5× 44 0.5× 146 2.6× 59 1.1× 38 721
Qilai Huang China 18 589 1.5× 69 0.5× 75 0.8× 149 2.7× 85 1.5× 50 978
Naheed Fatima Pakistan 18 407 1.1× 131 1.0× 36 0.4× 45 0.8× 62 1.1× 52 931
Alessandro Bolli Italy 19 524 1.4× 55 0.4× 226 2.4× 69 1.2× 110 2.0× 29 987

Countries citing papers authored by Fangfang Zhong

Since Specialization
Citations

This map shows the geographic impact of Fangfang Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Zhong more than expected).

Fields of papers citing papers by Fangfang Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Zhong. The network helps show where Fangfang Zhong may publish in the future.

Co-authorship network of co-authors of Fangfang Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Zhong. A scholar is included among the top collaborators of Fangfang Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Zhong. Fangfang Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Kehao, Lei Jin, Fangfang Zhong, et al.. (2024). Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China. Frontiers in Endocrinology. 15. 2 indexed citations
2.
Lu, Zhengyang, Gui Mei, Fangfang Zhong, et al.. (2024). Iridoids and lignans from Valeriana officinalis and their bioactivities. Phytochemistry. 229. 114311–114311.
4.
Zhong, Fangfang, Lijun Song, Hao Li, et al.. (2024). Multi-omics evaluation of the prognostic value and immune signature of FCN1 in pan-cancer and its relationship with proliferation and apoptosis in acute myeloid leukemia. Frontiers in Genetics. 15. 1425075–1425075. 2 indexed citations
5.
Zhong, Fangfang, et al.. (2024). The structure of the diheme cytochrome c4 from Neisseria gonorrhoeae reveals multiple contributors to tuning reduction potentials. Journal of Inorganic Biochemistry. 253. 112496–112496.
6.
Liu, Fangcen, Fangfang Zhong, Yao Fu, et al.. (2023). Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers. The Oncologist. 28(3). e136–e144. 9 indexed citations
8.
9.
Zhong, Fangfang, et al.. (2022). Influence of the Interdomain Interface on Structural and Redox Properties of Multiheme Proteins. Inorganic Chemistry. 61(51). 20949–20963. 1 indexed citations
10.
Clay, Michelle E., John H. Hammond, Fangfang Zhong, et al.. (2020). Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin. Proceedings of the National Academy of Sciences. 117(6). 3167–3173. 37 indexed citations
11.
Zhong, Fangfang, Xiaoming Huang, Na Zhang, et al.. (2020). High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia. Current Problems in Cancer. 45(3). 100673–100673. 5 indexed citations
12.
Zhong, Fangfang, et al.. (2020). Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review. Bosnian Journal of Basic Medical Sciences. 21(2). 136–144. 9 indexed citations
13.
Zhong, Fangfang, et al.. (2020). Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145. PeerJ. 8. e9337–e9337. 6 indexed citations
14.
Xiong, Hui, et al.. (2020). Anti-inflammatory and antiproliferative prenylated sulphur-containing amides from the leaves of Glycosmis pentaphylla. Fitoterapia. 146. 104693–104693. 19 indexed citations
15.
Zhong, Fangfang, et al.. (2018). The K79G Mutation Reshapes the Heme Crevice and Alters Redox Properties of Cytochromec. Biochemistry. 57(40). 5827–5840. 11 indexed citations
16.
Zhong, Fangfang, George P. Lisi, Daniel P. Collins, John H. Dawson, & Ekaterina V. Pletneva. (2014). Redox-dependent stability, protonation, and reactivity of cysteine-bound heme proteins. Proceedings of the National Academy of Sciences. 111(3). E306–15. 50 indexed citations
17.
Zhong, Fangfang, et al.. (2014). Carcinoma arising in microglandular adenosis of the breast: triple negative phenotype with variable morphology. Pathology. 46. S53–S54. 20 indexed citations
18.
Zhong, Fangfang, Jie Pan, Xiaoxiao Liu, et al.. (2011). A novel insight into the heme and NO/CO binding mechanism of the alpha subunit of human soluble guanylate cyclase. JBIC Journal of Biological Inorganic Chemistry. 16(8). 1227–1239. 12 indexed citations
19.
Chen, Yu, et al.. (2010). Two New Prenylated Xanthones from the Bark of Garcinia xanthochymus. Bulletin of the Korean Chemical Society. 31(11). 3418–3420. 10 indexed citations
20.
Chen, Yu, et al.. (2008). Structure elucidation and NMR spectral assignment of five new xanthones from the bark of Garcinia xanthochymus. Magnetic Resonance in Chemistry. 46(12). 1180–1184. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026